News 10. Jan. 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 04. Dez. 2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
News 23. Aug. 2023 Sion’s Pôle Santé takes shape with the laying of the first stone Valued at CHF 86 million, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in the healthca...
Actualités 15. Dez. 2021 La Source lance la plateforme d’innovation collaborative H4 Avec H4, La Source ouvre la première plateforme d’innovation collaborative dédiée aux soins et à la santé dans le canton de Vaud.
Actualités 16. Nov. 2021 Un hub dédié à l’innovation médicale à la Clinique de Genolier La clinique de Genolier et le groupe privé Swiss Medical Network ont posé la première pierre d'un nouveau pôle dédié à l'innovation médicale. Est...
News 27. Juni 2023 Axe Santé, the canton of Valais’ center for sustainable health technologies Axe Santé, an interdisciplinary health technology development center, serves as a hub that unifies all the research institutes of the HES-SO Vala...
News 24. Mai 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
News 15. Dez. 2021 La Source launches the H4 collaborative innovation hub With H4, La Source is opening the first collaborative innovation platform dedicated to healthcare in the canton of Vaud.
Success stories 09. Juni 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
News 16. Nov. 2021 A hub dedicated to medical innovation at the Clinique de Genolier The Clinique de Genolier and the Swiss Medical Network Group have laid the first stone of a new hub dedicated to medical innovation. Estimated at...
S-GE イベント オンラインセミナー 「スイスと欧州から実現させるサーキュラーエコノミー」 / Circular Economy Realization for Japanese Companies through the Performance of Switzerland and Europe
Actualités 30. Apr. 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 03. Mai 2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...
Success stories 21. Apr. 2021 Deloitte’s Future of Health Initiative: “We have all of the parts of the value chain here, from R&D to manufacturing to commercialization.“ Switzerland is an important hub for the life sciences industry. It is the second largest exporter of packaged medicines in the world and home to ...
News 13. Juli 2021 Merck reaches key milestone in the construction of its Biotech Development Center Merck has celebrated the completion of the structural work on its Biotech Development Center currently under construction in Corsier-sur-Vevey.
Success stories 25. Mai 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
Success stories 25. Mai 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...